rs11042950

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000360.4(TH):​c.487+3G>A variant causes a splice donor region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00992 in 1,612,286 control chromosomes in the GnomAD database, including 124 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0081 ( 10 hom., cov: 32)
Exomes 𝑓: 0.010 ( 114 hom. )

Consequence

TH
NM_000360.4 splice_donor_region, intron

Scores

2
Splicing: ADA: 0.0005839
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.98
Variant links:
Genes affected
TH (HGNC:11782): (tyrosine hydroxylase) The protein encoded by this gene is involved in the conversion of tyrosine to dopamine. It is the rate-limiting enzyme in the synthesis of catecholamines, hence plays a key role in the physiology of adrenergic neurons. Mutations in this gene have been associated with autosomal recessive Segawa syndrome. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 11-2168488-C-T is Benign according to our data. Variant chr11-2168488-C-T is described in ClinVar as [Benign]. Clinvar id is 242254.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-2168488-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00809 (1232/152268) while in subpopulation SAS AF= 0.0126 (61/4824). AF 95% confidence interval is 0.0101. There are 10 homozygotes in gnomad4. There are 633 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 10 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
THNM_000360.4 linkuse as main transcriptc.487+3G>A splice_donor_region_variant, intron_variant ENST00000352909.8
THNM_199292.3 linkuse as main transcriptc.580+3G>A splice_donor_region_variant, intron_variant
THNM_199293.3 linkuse as main transcriptc.568+3G>A splice_donor_region_variant, intron_variant
THXM_011520335.3 linkuse as main transcriptc.499+3G>A splice_donor_region_variant, intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
THENST00000352909.8 linkuse as main transcriptc.487+3G>A splice_donor_region_variant, intron_variant 1 NM_000360.4 P1P07101-3

Frequencies

GnomAD3 genomes
AF:
0.00809
AC:
1231
AN:
152150
Hom.:
10
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0109
Gnomad ASJ
AF:
0.0187
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0124
Gnomad FIN
AF:
0.0110
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0105
Gnomad OTH
AF:
0.00860
GnomAD3 exomes
AF:
0.00946
AC:
2298
AN:
242896
Hom.:
23
AF XY:
0.00974
AC XY:
1295
AN XY:
133018
show subpopulations
Gnomad AFR exome
AF:
0.00153
Gnomad AMR exome
AF:
0.00732
Gnomad ASJ exome
AF:
0.0180
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0106
Gnomad FIN exome
AF:
0.0105
Gnomad NFE exome
AF:
0.0113
Gnomad OTH exome
AF:
0.0140
GnomAD4 exome
AF:
0.0101
AC:
14762
AN:
1460018
Hom.:
114
Cov.:
34
AF XY:
0.0102
AC XY:
7441
AN XY:
726344
show subpopulations
Gnomad4 AFR exome
AF:
0.00131
Gnomad4 AMR exome
AF:
0.00736
Gnomad4 ASJ exome
AF:
0.0184
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0116
Gnomad4 FIN exome
AF:
0.0118
Gnomad4 NFE exome
AF:
0.0104
Gnomad4 OTH exome
AF:
0.00976
GnomAD4 genome
AF:
0.00809
AC:
1232
AN:
152268
Hom.:
10
Cov.:
32
AF XY:
0.00850
AC XY:
633
AN XY:
74440
show subpopulations
Gnomad4 AFR
AF:
0.00216
Gnomad4 AMR
AF:
0.0109
Gnomad4 ASJ
AF:
0.0187
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.0126
Gnomad4 FIN
AF:
0.0110
Gnomad4 NFE
AF:
0.0105
Gnomad4 OTH
AF:
0.00851
Alfa
AF:
0.00980
Hom.:
4
Bravo
AF:
0.00777
Asia WGS
AF:
0.00693
AC:
24
AN:
3478
EpiCase
AF:
0.0122
EpiControl
AF:
0.0113

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024TH: BP4, BS1, BS2 -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxApr 20, 2018This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Autosomal recessive DOPA responsive dystonia Benign:3
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -
TH-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesApr 19, 2023This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsAug 10, 2017- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
17
DANN
Benign
0.77

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00058
dbscSNV1_RF
Benign
0.0080
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs11042950; hg19: chr11-2189718; API